Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS10018826
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10018826
Fusion event
HBV-MRO integration
Validated
No
Detection method
VirusFinder
Data source
Curated
Sample type
Nontumor
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2017
PubMed ID
29212479
Virus Sequence
Virus name
HBV
Reference genome
NC_003977
Start
1717
Integrated sequence
CACCGTGAACGCCCACCAAATATTGCCCAAGGTCTTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGAC| |TGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCAT
Host Sequence
Chromosome
chr18
Cytoband
q21.2
Reference genome
GRCh37.55
Start
48325599/50799229 (Hg38)
End
48325599/50799229 (Hg38)
Location type
Exon1
Target gene
MRO
miRNAs that regulate target gene
hsa-mir-2110
;
hsa-mir-491-5p
;
hsa-mir-6780b-5p
;
hsa-mir-4725-3p
;
hsa-mir-4271
;
hsa-mir-5196-5p
;
hsa-mir-4747-5p
;
hsa-mir-3202
;
hsa-mir-3179
;
hsa-mir-203a-3p
;
hsa-mir-6783-5p
;
hsa-mir-3611
;
hsa-mir-3140-3p
;
hsa-mir-7706
;
hsa-mir-4325
;
hsa-mir-7703
;
hsa-mir-616-3p
;
hsa-mir-4537
;
hsa-mir-187-3p
;
hsa-mir-4317
;
hsa-mir-6774-3p
;
hsa-mir-92b-3p
;
hsa-mir-92a-3p
;
hsa-mir-367-3p
;
hsa-mir-363-3p
;
hsa-mir-32-5p
;
hsa-mir-25-3p
;
hsa-mir-6513-5p
;
hsa-mir-887-5p
;
hsa-mir-3913-5p
;
hsa-mir-3122
;
hsa-mir-450a-1-3p
;
hsa-mir-6780a-5p
;
hsa-mir-6779-5p
;
hsa-mir-3689c
;
hsa-mir-3689b-3p
;
hsa-mir-3689a-3p
;
hsa-mir-30b-3p
;
hsa-mir-1273h-5p
;
hsa-mir-6788-5p
;
hsa-mir-30c-2-3p
;
hsa-mir-30c-1-3p
;
hsa-mir-7977
;
hsa-mir-8085
;
hsa-mir-6731-5p
;
hsa-mir-6878-5p
;
hsa-mir-24-3p
;
hsa-mir-4284
;
hsa-mir-4786-5p
;
hsa-mir-383-3p
;
hsa-mir-4761-5p
;
hsa-mir-6516-5p
;
hsa-mir-455-3p
;
hsa-mir-6499-3p
;
hsa-mir-6086
;
hsa-mir-377-5p
;
hsa-mir-548s
;
hsa-mir-6864-3p
;
hsa-mir-3672
;
hsa-mir-4684-5p
;
hsa-mir-3926
;
hsa-mir-769-5p
;
hsa-mir-3190-5p
;
hsa-mir-6827-3p
;
hsa-mir-340-3p
;
hsa-mir-6849-3p
;
hsa-mir-6771-3p
;
hsa-mir-548x-3p
;
hsa-mir-548j-3p
;
hsa-mir-548aq-3p
;
hsa-mir-548am-3p
;
hsa-mir-548aj-3p
;
hsa-mir-548ah-3p
;
hsa-mir-548ae-3p
;
hsa-mir-548z
;
hsa-mir-548h-3p
;
hsa-mir-548d-3p
;
hsa-mir-548bb-3p
;
hsa-mir-548ac
;
hsa-mir-210-5p
;
hsa-mir-4749-3p
;
hsa-mir-2276-3p
;
hsa-mir-1248
;
hsa-mir-6810-3p
;
hsa-mir-6801-3p
;
hsa-mir-30e-5p
;
hsa-mir-30d-5p
;
hsa-mir-30c-5p
;
hsa-mir-30b-5p
;
hsa-mir-30a-5p
;
hsa-mir-4693-3p
;
hsa-mir-4461
;
hsa-mir-4279
;
hsa-mir-630
;
hsa-mir-570-5p
;
hsa-mir-548ba
;
hsa-mir-548ai
;
hsa-mir-548ag
;
hsa-mir-7109-3p
;
hsa-mir-1273e
;
hsa-mir-3689d
;
hsa-mir-4459
;
hsa-mir-6134
;
hsa-mir-665
;
hsa-mir-6840-3p
;
hsa-mir-6851-5p
;
hsa-mir-6880-5p
;
hsa-mir-7847-3p
;
hsa-mir-3157-5p
;
hsa-mir-4691-3p
;
hsa-mir-6787-3p
Nearest miRNA
hsa-mir-1-2/Upstream/672666; hsa-mir-122/Downstream/2437872;
Nearest TSS
ENST00000575820/Upstream/134930;
ENST00000638768/Downstream/20397;
Nearest CpG islands
None/Target,
chr18-CpG: 67/Upstream/69240
,
chr18-CpG: 109/Downstream/79536
Upstream sequence
TGCTTGGGTGGATCTGTATGTGTGCATAAGTGTACATCTATGAGCTAAATTTTCACAGCCATTTGCCAAGATTAAGGAACAAAATAGGTGTCTAAAGATA
Downstream sequence
AATCCCAAGAGGCAAGCAGTGAGAAGAGGCATCCAGTGAGATAAAACAGGGGAACATGATGGCTCAGCAATGCACTCATACAGAACCATTTCCCTGCTGC
Reference
Yoo, S., et al. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med ,2017, 15(1): 214.
Sample Information
×
Sample name
P75D
Sample type
Nontumor
Gender
Female
CpG Island Information
×
Download
Curate